Skip to main
DBD
DBD logo

DBD Stock Forecast & Price Target

DBD Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Diebold Nixdorf Inc is experiencing a positive trend in retail sales, particularly in Europe, anticipated to increase both sequentially and year-over-year in the third and fourth quarters. The company's financial position has improved significantly, with expectations of nearly doubling free cash flow to an estimated $205 million by 2025, indicating strong operational performance. Additionally, the enhancement of the balance sheet and liquidity reflects a robust capacity for free cash flow conversion, further supporting a favorable outlook for the company's financial health.

Bears say

Diebold Nixdorf Inc faces significant financial risks that contribute to a negative outlook for its stock, primarily due to challenges in offsetting tariff-related costs amid a volatile trade environment. The company is also experiencing disruptions in product shipments and services linked to the COVID-19 pandemic, alongside uncertainty in upgrade and replacement activity within its critical Banking vertical, which impacts revenue predictability. Furthermore, currency exchange volatility, particularly related to the BRL, EUR, and GBP, alongside a low average daily trading volume, signifies potential liquidity issues that could adversely affect investor confidence.

DBD has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Diebold Nixdorf Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Diebold Nixdorf Inc (DBD) Forecast

Analysts have given DBD a Buy based on their latest research and market trends.

According to 2 analysts, DBD has a Buy consensus rating as of Nov 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Diebold Nixdorf Inc (DBD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.